Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000945621-22-000208
Filing Date
2022-04-18
Accepted
2022-04-18 17:16:59
Documents
1
Effectiveness Date
2022-04-18
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8934
  Complete submission text file 0000945621-22-000208.txt   10071
Mailing Address 100 PEARL STREET, 27TH FLOOR NEW YORK NY 10004
Business Address 100 PEARL STREET, 27TH FLOOR NEW YORK NY 10004 212-806-8800
Alger Life Sciences Innovation Fund LP (Filer) CIK: 0001923614 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-442344 | Film No.: 22832800